← Eichor
Study identifier: NCT07557706 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

Condition: PARKINSON DISEASE (Disorder)  ·  Sponsor: University of Alabama at Birmingham

PhasePhase 1
Planned participants24
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study is to find out whether a type of gentle nerve stimulation, called transcutaneous auricular Vagus Nerve Stimulation (taVNS), can help improve how the body regulates heart rate and blood pressure in people with Parkinson's Disease (PD). Problems with heart rate and blood pressure control are common and can make it harder for people to exercise or do daily activities. By using this non-invasive form of nerve stimulation and testing how it affects the body's natural responses, this study hopes to learn if taVNS could be a helpful tool to support physical therapy and improve overall function.

This description comes directly from the study's public registry record.

Talk to the study team

Alexandra Evancho, DPT  ·  205-975-5221  ·  amelgin@uab.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Wellness, Health and Research Facility at UABBirmingham, Alabama, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07557706